Ethics of care for the micropreemies. Just because we can, should we?

Area of Science:

• Neonatal Medicine
• Perinatal Care
• Medical Ethics

Background:

• The management of extremely premature infants (born at 22-23 weeks gestation) is debated, with approaches ranging from non-resuscitation to universal resuscitation.
• Discrepancies exist among medical professionals, institutions, and societies regarding the preferred treatment strategy for these vulnerable neonates.
• Concerns regarding survival rates, neurodevelopmental impairment in survivors, and healthcare costs influence treatment decisions.

Purpose of the Study:

• To examine the evolving debate surrounding treatment approaches for extremely premature infants.
• To present evidence supporting active treatment for babies born at 22 and 23 weeks gestation.
• To address ethical considerations in neonatal care for extremely preterm infants.

Main Methods:

• Review of current medical literature and studies on outcomes for extremely premature infants.
• Analysis of differing perspectives on resuscitation and active treatment strategies.
• Comparison of survival rates and neurodevelopmental outcomes between treatment approaches.

Main Results:

• Survival rates for infants born at 22 and 23 weeks gestation are improving in centers providing active treatment.
• Many survivors of active treatment demonstrate positive neurodevelopmental outcomes.
• Neonatal intensive care unit (NICU) care for extremely preterm infants is considered cost-effective relative to other medical interventions.

Conclusions:

• Active treatment for babies born at 22-23 weeks gestation is increasingly supported by evidence of improved survival and neurodevelopmental outcomes.
• The traditional concerns about survival, impairment, and cost are being challenged by data from centers offering aggressive care.
• The debate highlights fundamental ethical questions within neonatology concerning the value of life and resource allocation for extremely premature infants.